Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -5.07%10.68B | 51.07%3.14B | -0.31%3.14B | -38.64%2.12B | -11.19%2.29B | 14.47%11.25B | -10.87%2.08B | 19.84%3.15B | 48.83%3.45B | 0.89%2.57B |
Cost of revenue | -8.29%8.17B | 16.15%2.21B | 3.68%2.53B | -37.11%1.68B | -7.63%1.76B | 15.97%8.91B | 4.38%1.9B | 22.50%2.44B | 46.71%2.67B | -7.31%1.9B |
Gross profit | 7.28%2.5B | 433.12%927.36M | -14.00%610.78M | -43.91%436.17M | -21.28%527.98M | 9.08%2.33B | -65.69%173.95M | 11.52%710.23M | 56.62%777.64M | 34.69%670.74M |
Operating expense | 15.87%894.09M | 7.22%239.96M | 29.47%216.55M | 29.78%213.36M | 3.72%224.23M | 7.15%771.65M | 25.31%223.8M | -8.42%167.26M | -7.73%164.4M | 19.60%216.19M |
Staff costs | 14.46%356.6M | ---- | ---- | ---- | ---- | -11.35%311.55M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | -29.53%36.35M | ---- | ---- | ---- | ---- | 22.03%51.58M | ---- | ---- | ---- | ---- |
-General and administrative expense | -29.53%36.35M | ---- | ---- | ---- | ---- | 22.03%51.58M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 84.50%42.84M | ---- | ---- | ---- | ---- | -4.70%23.22M | ---- | ---- | ---- | ---- |
-Depreciation | 84.50%42.84M | ---- | ---- | ---- | ---- | -4.70%23.22M | ---- | ---- | ---- | ---- |
Rent and land expenses | 723.17%96.3M | ---- | ---- | ---- | ---- | --11.7M | ---- | ---- | ---- | ---- |
Other operating expenses | -3.10%362.01M | ---- | ---- | ---- | ---- | 23.67%373.6M | ---- | ---- | ---- | ---- |
Operating profit | 3.03%1.61B | 1,479.08%687.4M | -27.39%394.23M | -63.67%222.81M | -33.18%303.75M | 10.07%1.56B | -115.18%-49.85M | 19.53%542.98M | 92.64%613.24M | 43.29%454.55M |
Net non-operating interest income (expenses) | 13.58%8.11M | 81.04%-289K | 20.24%4.57M | -27.87%2.01M | -12.41%1.81M | 47.55%7.14M | -335.43%-1.52M | 30.36%3.8M | 178.92%2.79M | 62.81%2.07M |
Non-operating interest income | 0.42%9.39M | 13.41%186K | 5.81%4.57M | -0.11%2.79M | -11.15%1.84M | 26.11%9.35M | 13.10%164K | 21.64%4.32M | 32.76%2.79M | 28.47%2.07M |
Non-operating interest expense | -42.18%1.28M | -71.86%475K | --0 | --775K | --26K | -14.22%2.21M | 241.01%1.69M | -18.40%519K | --0 | --0 |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 1.23M | 0 | 0 | 0 | ||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 7.07M | -4.03M | 12.39M | -1.08M | -211K | 0 | 0 | 0 | 0 | 0 |
Less:Other special charges | ---7.07M | --4.03M | ---12.39M | --1.08M | --211K | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -26.06%23.91M | -89.35%2.27M | -2.11%3.53M | 12.12%4.06M | 272.30%14.04M | 177.16%32.33M | 517.99%21.33M | -0.66%3.61M | 84.94%3.62M | 43.70%3.77M |
Income before tax | 3.01%1.65B | 2,381.60%685.35M | -24.42%415.96M | -63.24%227.81M | -30.63%319.4M | 11.58%1.6B | -109.06%-30.04M | 19.49%550.38M | 92.99%619.66M | 43.37%460.39M |
Income tax | 8.69%558.28M | 273.93%184.37M | -25.31%155.66M | -63.19%87.3M | -24.76%130.95M | 10.01%513.62M | -310.11%-106M | 19.47%208.42M | 93.59%237.17M | 45.69%174.04M |
Net income | 0.32%1.09B | 559.52%500.98M | -23.88%260.3M | -63.27%140.51M | -34.19%188.44M | 12.34%1.09B | -72.97%75.96M | 19.51%341.97M | 92.61%382.49M | 42.00%286.35M |
Net income continuous operations | 0.32%1.09B | 559.52%500.98M | -23.88%260.3M | -63.27%140.51M | -34.19%188.44M | 12.34%1.09B | -72.97%75.96M | 19.51%341.97M | 92.61%382.49M | 42.00%286.35M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 0.32%1.09B | 559.52%500.98M | -23.88%260.3M | -63.27%140.51M | -34.19%188.44M | 12.34%1.09B | -72.97%75.96M | 19.51%341.97M | 92.61%382.49M | 42.00%286.35M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 0.32%1.09B | 559.52%500.98M | -23.88%260.3M | -63.27%140.51M | -34.19%188.44M | 12.34%1.09B | -72.97%75.96M | 19.51%341.97M | 92.61%382.49M | 42.00%286.35M |
Gross dividend payment | ||||||||||
Basic earnings per share | 0.32%250.66 | 559.68%115.18 | -23.87%59.85 | -63.27%32.3 | -34.19%43.33 | 12.34%249.86 | -72.98%17.46 | 19.50%78.62 | 92.60%87.94 | 42.02%65.84 |
Diluted earnings per share | 0.32%250.66 | 559.68%115.18 | -23.88%59.8473 | -63.27%32.3 | -34.19%43.33 | 12.34%249.86 | -72.98%17.46 | 19.51%78.62 | 92.61%87.9391 | 42.02%65.84 |
Dividend per share | 0.00%80 | 0.00%80 | 0 | 0 | 0 | 17.65%80 | 17.65%80 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |